EDAP vs. ZYXI, AXGN, SMLR, OM, ELMD, FONR, VANI, HYPR, RMTI, and CUTR
Should you be buying Edap Tms stock or one of its competitors? The main competitors of Edap Tms include Zynex (ZYXI), AxoGen (AXGN), Semler Scientific (SMLR), Outset Medical (OM), Electromed (ELMD), FONAR (FONR), Vivani Medical (VANI), Hyperfine (HYPR), Rockwell Medical (RMTI), and Cutera (CUTR).
Edap Tms (NASDAQ:EDAP) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability, valuation and community ranking.
Zynex has higher revenue and earnings than Edap Tms. Edap Tms is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.
Edap Tms has a beta of 0.65, indicating that its share price is 35% less volatile than the S&P 500. Comparatively, Zynex has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500.
Zynex has a net margin of 4.33% compared to Edap Tms' net margin of -30.12%. Zynex's return on equity of 16.34% beat Edap Tms' return on equity.
Edap Tms received 323 more outperform votes than Zynex when rated by MarketBeat users. Likewise, 62.84% of users gave Edap Tms an outperform vote while only 51.16% of users gave Zynex an outperform vote.
In the previous week, Edap Tms had 1 more articles in the media than Zynex. MarketBeat recorded 2 mentions for Edap Tms and 1 mentions for Zynex. Zynex's average media sentiment score of 1.44 beat Edap Tms' score of 0.96 indicating that Zynex is being referred to more favorably in the news media.
62.7% of Edap Tms shares are owned by institutional investors. Comparatively, 29.7% of Zynex shares are owned by institutional investors. 0.2% of Edap Tms shares are owned by insiders. Comparatively, 52.1% of Zynex shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Edap Tms presently has a consensus price target of $14.00, suggesting a potential upside of 135.29%. Zynex has a consensus price target of $18.00, suggesting a potential upside of 77.34%. Given Edap Tms' higher possible upside, analysts plainly believe Edap Tms is more favorable than Zynex.
Summary
Zynex beats Edap Tms on 9 of the 16 factors compared between the two stocks.
Get Edap Tms News Delivered to You Automatically
Sign up to receive the latest news and ratings for EDAP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EDAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Edap Tms Competitors List
Related Companies and Tools
